Table 3.
Group | No. (%) of patients with an HBsAb concn of: |
||
---|---|---|---|
<10 mIU/ml | 10–100 mIU/ml | >100 mIU/ml | |
A | 25 (43.9) | 14 (24.5) | 18 (31.6) |
B | 16 (34.8) | 20 (43.5) | 10 (21.7) |
C | 35 (58.3) | 18 (30) | 7 (11.7) |
P < 0.05 for group A versus group B for HBsAb 10–100 mIU/ml, for group A versus group B for HBsAb >100 mIU/ml, and for group B versus group C for HBsAb <10 mIU/ml.